1Matthys P,Vermeire K,Heremans H,et al.The protective effect of IFN-gamma in experimental autoimmune diseases:a central role of mycobacterial adjuvant-induced myelopoiesis[J].J Leukoc Biol,2000,68(4):447-454.
2Baltazar Lde M,Santos PC,Paula TP,et al.IFN-γimpairs Trichophyton rubrum proliferation in a murine model of dermatophytosis through the production of IL-1βand reactive oxygen species[J].Med Mycol,2014,52(3):293-302.
4Mahaley MS Jr,Bertsch L,Cush S,et al.Systemic gamma-interferon therapy for recurrent gliomas[J].J Neurosurg,1988,69(6):826-829.
5Nemunaitis J,Fong T,Robbins JM,et al.Phase I trial of interferongamma(IFN-gamma)retroviral vector administered intratumorally to patients with metastatic melanoma[J].Cancer Gene Ther,1999,6(4):322-330.
6Schwartzberg LS,Petak I,Stewart C,et al.Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer:phase I trial and correlative studies of IFN-gamma,5-fluorouracil,and leucovorin[J].Clin Cancer Res,2002,8(8):2488-2498.
7Ma Z,Sun W.The effect of aerosol polyethylenimine/interferon-γplasmid complexes on expression of inflammatory cytokines in mouse lung[J].J Aerosol Med Pulm Drug Deliv,2014,27(2):117-124.
8Alton EW,Armstrong DK,Ashby D,et al.Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis:a randomised,double-blind,placebo-controlled,phase 2b trial[J].Lancet Respir Med,2015,3(9):684-691.
9Wu J,Zhou L,Liu J,et al.The efficacy of thymosin alpha 1 for severe sepsis(ETASS):a multicenter,single-blind,randomized and controlled trial[J].Crit Care,2013,17(1):R8.
